Mesoblast (MESO) director William Murray Burns reports options and 226,250 shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Mesoblast Ltd director William Murray Burns filed an initial Form 3 showing his beneficial holdings in the company. The filing lists several option awards over Ordinary Shares with exercise prices ranging from $0.36 to $1.81 per share and expirations between 2026 and 2031. It also reports direct ownership of 226,250 Ordinary Shares as of the reporting date. These entries reflect existing positions rather than new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
BURNS WILLIAM MURRAY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 33,333 shares (Direct);
Ordinary Shares — 226,250 shares (Direct)
Footnotes (1)
Key Figures
Direct Ordinary Shares held: 226,250 shares
Option exercise price: $1.81 per share
Low-strike options: $0.36 per share
+1 more
4 metrics
Direct Ordinary Shares held
226,250 shares
Total Ordinary Shares directly owned as of reporting date
Option exercise price
$1.81 per share
Options over 33,333–33,334 Ordinary Shares expiring November 17, 2026
Low-strike options
$0.36 per share
Options over 136,550–136,551 Ordinary Shares expiring October 11, 2030
Mid-strike options
$0.97 per share
Options over 50,000 Ordinary Shares expiring August 26, 2031
Key Terms
Form 3, Option (right to buy, Ordinary Shares, exercise price
4 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3): initial statement of beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Option (right to buy financial
""security_title": "Option (right to buy)", showing derivative awards over shares"
exercise price financial
""conversion_or_exercise_price": "0.3600" and other listed option prices"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What does the Mesoblast (MESO) Form 3 filing by William Murray Burns show?
The Form 3 shows William Murray Burns’ existing beneficial ownership in Mesoblast, including several option grants over Ordinary Shares and 226,250 Ordinary Shares held directly. It is an initial disclosure of holdings, not a report of new purchases or sales.
Do the Mesoblast (MESO) Form 3 entries show any insider buying or selling?
No explicit insider buying or selling is shown. All entries are coded as holdings with an unknown transaction code, and the transaction summary reports zero buy and sell transactions, indicating this filing is a position snapshot rather than trade disclosure.
What are the key expiration dates for William Murray Burns’ Mesoblast (MESO) options?
The filing discloses option positions expiring on November 17, 2026, October 11, 2030, and August 26, 2031. These dates indicate the periods during which Burns can exercise his rights to acquire Mesoblast Ordinary Shares at the stated exercise prices.